← SynDRA
VADADUSTAT
SynDRA canonical compound SYN0038362 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EGLN1 | EGLN2 | EGLN3 |
|---|
| Mechanism of action | hypoxia inducible factor prolyl hydroxylase inhibitor |
|---|
All known targets
- EGLN1
- EGLN2
- EGLN3
- A085R
- HIF1AN
- OGFOD1
- VEGFA
Mechanisms of action (all sources)
- EGLN1 INHIBITOR
- Egl nine homolog 1 inhibitor
- EGLN3 INHIBITOR
- Egl nine homolog 3 inhibitor
- EGLN2 INHIBITOR
- Hypoxia-inducible factor prolyl hydroxylase 1 inhibitor
- hypoxia inducible factor prolyl hydroxylase inhibitor
Drug classes
- Prolyl-Hydroxylase Inhibitors
ATC classes
- B03X · OTHER ANTIANEMIC PREPARATIONS
Cross-references
Synonyms
- vafseo
- AKB-6548
- MT-6548
- PG-1016548
- Vafseo
- B-506
- B506
- PG1016548
- I60W9520VV
- N-(5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine
- AKB6548
- N-[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]glycine
- vadadustatum
- RefChem:901563
- DTXCID801611280
- Vadadustat [USAN]
- (5-(3-chlorophenyl)-3-hydroxypicolinoyl)glycine
- UNII-I60W9520VV
- Vadadustat?
- A1Z
- Vafseo (TN)
- VADADUSTAT [INN]
- VADADUSTAT [JAN]
- VADADUSTAT [WHO-DD]
- Vadadustat (JAN/USAN/INN)
- orb2281186
- SCHEMBL1920738
- SCHEMBL29357486
- SCHEMBL29405970
- GTPL11831
- JGRXMPYUTJLTKT-UHFFFAOYSA-N
- BDBM107704
- GLXC-10623
- EX-A2573
- GSK128863
- MFCD30470233
- s6490
- AKOS028114979
Look up VADADUSTAT in the interactive SynDRA portal →